Dendrobine
CAS No. 2115-91-5
Dendrobine( —— )
Catalog No. M18236 CAS No. 2115-91-5
Dendrobine has a slight but demonstrable analgesic and antipyretic action.Dendrobine produces moderate hyperglycemia, diminishes cardiac activity in large doses, lowers the blood pressure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 72 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 204 | In Stock |
|
| 50MG | 296 | In Stock |
|
| 100MG | 436 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDendrobine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDendrobine has a slight but demonstrable analgesic and antipyretic action.Dendrobine produces moderate hyperglycemia, diminishes cardiac activity in large doses, lowers the blood pressure.
-
DescriptionDendrobine has a slight but demonstrable analgesic and antipyretic action. Dendrobine produces moderate hyperglycemia, diminishes cardiac activity in large doses, lowers the blood pressure. 3. Dendrobine on the electrical activity and on amino acid-induced depolarizations of primary afferent terminals were tested on the frog isolated spinal cord.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number2115-91-5
-
Formula Weight263.38
-
Molecular FormulaC16H25NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (126.55 mM)
-
SMILESCC(C)C1C2C3CCC4C3(C(C1OC2=O)N(C4)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
3',4',5',5,7-Pentame...
It is an organic compound with fomular C20H22O7.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
Methylswertianin
Methylswertianin is an active constituent in Swertia punicea Hemsl, with anti-diabetic effect. Methylswertianincan abates type-2 diabetes, likely via the improvement of insulin resistance (IR).
Cart
sales@molnova.com